Main
>
ONCOLOGY (**)
>
Lung>NSCLC>EGFR+>MET>***
>
Treatment
>
Co: UK. A. Osimertinib
>
(*) USA 1st Line OK: 2018. 04.18.
(*) USA 1st Line OK: 2018. 04.18.'s products
This section has no products